GGrantIndex
← Leaderboards

Stephen W Byers

Georgetown University

$6,720,177
Attributed
$6,720,177
Total exposure
9
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,720,177 · 9

By mechanism

R01$4,801,182 · 3
P01$830,017 · 1
P30$450,158 · 2
P50$405,870 · 1
R21$232,950 · 1
P20$0 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Animals

Research focus

AnimalsCellsMalignant NeoplasmsCadherinsSignal TransductionTumorGenesMediatingInhibitor/AntagonistLigandsGrowthPathway InteractionsCell AdhesionAnimal ModelBreast NeoplasmsGene ExpressionSmall MoleculeVitamin DProgramsNuclear ReceptorsClinical TrialsMolecularEpitheliumDietary Supplements

Grant awards (30)

Shared Resource Management$126,011
P30 · FY2025 · CA · contact PI
Shared Resource Management$7,800
P30 · FY2025 · CA · contact PI
Shared Resource Management$90,921
P30 · FY2024 · CA · contact PI
Shared Resource - Proteomics & Metabolomics Shared Resource$112,713
P30 · FY2020 · CA · contact PI
Shared Resource - Proteomics & Metabolomics Shared Resource$112,713
P30 · FY2019 · CA · contact PI
Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)$581,173
R01 · FY2015 · CA · contact PI
Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)$566,047
R01 · FY2014 · CA · contact PI
Cadherin-11 in cancer and rheumatoid arthritis, common target, common therapies$69,975
R01 · FY2014 · CA · contact PI
Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)$550,881
R01 · FY2013 · CA · contact PI
Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)$615,290
R01 · FY2012 · CA · contact PI
Beta-catenin-specific regulation of the vitamin D pathway in colon cancer$308,958
R01 · FY2012 · CA · contact PI
Cross Regulation of TGFB/elf, B-catenin and Vitamin D Pathways in Gastrointestina$210,097
P01 · FY2012 · CA · contact PI
Beta-catenin-specific regulation of the vitamin D pathway in colon cancer$308,958
R01 · FY2011 · CA · contact PI
Beta-catenin-specific regulation of the vitamin D pathway in colon cancer$318,513
R01 · FY2010 · CA · contact PI
Cross Regulation of TGFB/elf, B-catenin and Vitamin D Pathways in Gastrointestina$224,740
P01 · FY2010 · CA · contact PI
Beta-catenin-specific regulation of the vitamin D pathway in colon cancer$318,513
R01 · FY2009 · CA · contact PI
Cross Regulation of TGFB/elf, B-catenin and Vitamin D Pathways in Gastrointestina$234,858
P01 · FY2009 · CA · contact PI
Beta-catenin-specific regulation of the vitamin D pathway in colon cancer$318,513
R01 · FY2008 · CA · contact PI
Cross Regulation of TGFB/elf, B-catenin and Vitamin D Pathways in Gastrointestina$160,322
P01 · FY2008 · CA · contact PI
Cross Regulation of Beta-catenin and Retinoid Signaling$254,528
R01 · FY2004 · DK
Cross Regulation of Beta-catenin and Retinoid Signaling$80,744
R01 · FY2004 · DK
Cross Regulation of Beta-catenin and Retinoid Signaling$222,712
R01 · FY2003 · DK
Cross Regulation of Beta-catenin and Retinoid Signaling$65,702
R01 · FY2003 · DK
Cross Regulation of Beta-catenin and Retinoid Signaling$220,675
R01 · FY2002 · DK
PREVENTION MODELS$135,290
P50 · FY2002 · CA
APC2 AND BREAST CANCER$116,400
R21 · FY2002 · CA
PREVENTION MODELS$135,290
P50 · FY2001 · CA
APC2 AND BREAST CANCER$116,550
R21 · FY2001 · CA
PATHWAYS MEDIATING EFFECTS OF VITAMIN D$0
P20 · FY2001 · CA
PREVENTION MODELS$135,290
P50 · FY2000 · CA